19/12/2014 21:16:48 Free Membership Login

   

Acadia

Visual Financials
Company Name: ACADIA Pharmaceuticals, Inc.
Ticker Symbol: ACAD
WWW Address: http://www.acadia-pharm.com
CEO: Uli Hacksell
No. of Employees: 26
Common Issue Type: CS
Business Description:ACADIA Pharmaceuticals Inc. is in the business of development and commercialization of small molecule drugs for the treatment of central nervous system disorders.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 32.99 Up 0.14 32.91 32.87 32.7 33.49 32.54 2097764
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 3,291.4 99.8 0.00 -0.44 0.00 0.0 0.0 33.49 - 15.64
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close32.98$
PE Ratio - LTM0.0
Market Capitalisation3,291.4mil
Latest Shares Outstanding99.8mil
Earnings pS (EPS)-0.44$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float57.6mil
Float as % of Shares Outstanding0.6%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue11.10%
Research & Devlopment (R&D) as % of Revenue23.30%
Gross Profit Margin100.0%
EBITDA Margin-3337.8%
Pre-Tax Profit Margin-3314.2%
Assets Turnover0.8%
Return on Assets (ROA)-25.5%
Return on Equity (ROE)-28.4%
Return on Capital Invested (ROCI)-28.4%
Current Ratio27.0
Leverage Ratio (Assets/Equity)1.0
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS1.82$
Cash pS0.00$
Book-Value pS3.31$
Tangible Book-Value pS1.83$
Cash Flow pS-0.62$
Free Cash Flow pS-0.62$
KEY FIGURES (LTM): Price info
Price/Book Ratio9.82
Price/Tangible Book Ratio0.00
Price/Cash Flow-52.9
Price/Free Cash Flow-52.6
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---33.4928.40311
4 Weeks33.4932.5432.5433.4928.403223
13 Weeks32.9832.98209134027.2433.493223
26 Weeks209134033.4933.4927.3333.493220
52 Weeks28.2328.2328.4333.4915.642820
YTD15.6415.64-33.4915.64436
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
22.0422.0426.6426.6433.490.650.65
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue277533651673143116731431
Income277533652775336575240843
Dividend75240843147593384147593384
Capital Spending372397160NA372397160
R&D21356685NA21356685
Normalized Inc.75240843NA75240843
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %3644
Earnings %262618
EPS %320275275
EPS $18889889
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio189118000
Quick Ratio (Acid Test)758000
Liquidity Ratio (Cash)0.00
Receivables Turnover55000
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS182131000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)372000
Debt Ratio6987000
Total Debt/Equity (Gearing Ratio)No
LT Debt/Equity
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities6987000
Interest Cover-1974000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM148,964,568.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow-71.73
Dividend Yield8049098
Price/Tangible Book Ratio - LTM212
Price/Book Ratio - LTM1474797
Price/Cash Flow Ratio27.0
Price/Free Cash Flow Ratio - LTM212
Price/Sales Ratio14.00
P/E Ratio (1 month ago) - LTM148964568
P/E Ratio (26 weeks ago) - LTM266316196
P/E Ratio (52 weeks ago) - LTM266316196
5-Y High P/E Ratio373123678
5-Y Low P/E Ratio362666185
5-Y Average P/E Ratio1556479
Current P/E Ratio as % of 5-Y Average P/E1556479
P/E as % of Industry Group1,387,668.0
P/E as % of Sector Segment1,387,668.0
Current 12 Month Normalized P/E Ratio - LTM1,521,039.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM27.0
Book Value pS - LTM1474797
Capital Invested pS0.00
Cash pS - LTM514274
Cash Flow pS - LTM30.58
Free Cash Flow pS - LTM30.58
Earnings pS (EPS)330
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-1974000
Net Profit Margin - 5YEAR AVRG.2014-10-31
Equity Productivity0.00
Return on Equity (ROE)182131000
Return on Equity (ROE) - 5YEAR AVRG.3245029007
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-100
Assets Productivity372,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.3245029007
Gross Profit Margin1387668
Gross Profit Margin - 5YEAR AVRG.-100
EBITDA Margin - LTM1157551
EBIT Margin - LTM1387668
Pre-Tax Profit Margin579000
Pre-Tax Profit Margin - 5YEAR AVRG.99770300
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle6,979,818
Revenue per Employee
Net Income per Employee
Average Collection Period
Receivables Turnover55000
Day's Inventory Turnover Ratio6979000
Inventory Turnover55000
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover372000
Revenue per $ Cash6552000
Revenue per $ Plant6552000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.99770300
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq acad141219 21:16